Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
1.800
-0.440 (-19.64%)
Mar 28, 2024, 2:51 PM EDT - Market open

Akebia Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
194.62292.48211.65294.64335207.74181.231.5400
Upgrade
Revenue Growth (YoY)
-33.46%38.19%-28.17%-12.05%61.26%14.63%11706.32%---
Upgrade
Cost of Revenue
74.1585.57150.67296.48145.347.770000
Upgrade
Gross Profit
120.47206.9260.98-1.83189.67199.97181.231.5400
Upgrade
Selling, General & Admin
100.23138.6174.14154.1149.4687.0627.0122.2118.514.68
Upgrade
Research & Development
63.08129.99147.85218.49322.97291.01230.89115.7943.0223.26
Upgrade
Other Operating Expenses
0.1815.933.493.413.530.070000
Upgrade
Operating Expenses
163.49284.52325.48375.99475.95378.14257.913861.5137.94
Upgrade
Operating Income
-43.02-77.6-264.5-377.83-286.29-178.16-76.67-136.46-61.51-37.94
Upgrade
Interest Expense / Income
6.0315.6919.948.87-0.79-6.150000
Upgrade
Other Expense / Income
2.870.94-2.41-1.860.79-0.08-3-0.71-0.8-0.91
Upgrade
Pretax Income
-51.93-94.23-282.02-384.84-286.29-171.93-73.67-135.75-60.72-37.03
Upgrade
Income Tax
0000-6.63-28.340000
Upgrade
Net Income
-51.93-94.23-282.02-384.84-279.66-143.59-73.67-135.75-60.72-37.03
Upgrade
Preferred Dividends
00000000086.9
Upgrade
Net Income Common
-51.93-94.23-282.02-384.84-279.66-143.59-73.67-135.75-60.72-123.93
Upgrade
Shares Outstanding (Basic)
1871831661381185844382615
Upgrade
Shares Outstanding (Diluted)
1871831661381185844382615
Upgrade
Shares Change
2.56%10.14%19.85%16.95%104.00%33.42%15.33%42.49%71.81%2732.05%
Upgrade
EPS (Basic)
-0.28-0.52-1.70-2.78-2.36-2.47-1.69-3.60-2.29-8.04
Upgrade
EPS (Diluted)
-0.28-0.52-1.70-2.78-2.36-2.47-1.69-3.60-2.29-8.04
Upgrade
Free Cash Flow
-23.38-73.27-253.02-110.71-264.1-99.1-57.7855.24-52.82-27.71
Upgrade
Free Cash Flow Per Share
-0.13-0.40-1.52-0.80-2.23-1.71-1.331.47-2.00-1.80
Upgrade
Gross Margin
61.90%70.74%28.81%-0.62%56.62%96.26%100.00%100.00%--
Upgrade
Operating Margin
-22.10%-26.53%-124.97%-128.23%-85.46%-85.76%-42.31%-8889.90%--
Upgrade
Profit Margin
-26.68%-32.22%-133.25%-130.61%-83.48%-69.12%-40.65%-8843.45%--
Upgrade
Free Cash Flow Margin
-12.02%-25.05%-119.55%-37.57%-78.83%-47.70%-31.88%3598.96%--
Upgrade
EBITDA
-4.05-43.26-225.96-343.32-250.67-175.66-73.05-135.45-60.62-36.99
Upgrade
EBITDA Margin
-2.08%-14.79%-106.76%-116.52%-74.83%-84.56%-40.31%-8824.17%--
Upgrade
Depreciation & Amortization
41.8535.2836.1332.6636.422.420.620.30.10.05
Upgrade
EBIT
-45.89-78.54-262.09-375.97-287.08-178.08-73.67-135.75-60.72-37.03
Upgrade
EBIT Margin
-23.58%-26.85%-123.83%-127.60%-85.70%-85.72%-40.65%-8843.45%--
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).